SouthState Corp’s IDEAYA Biosciences IDYA Stock Holding History

SouthState Corp’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-500	Closed	-$10.5K	–	1452
2025 Q2	$10.5K	Buy	+500	New	+$9.59K	﹤0.01%	773

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SouthState Corp's IDYA Position: Q3 2025 in Review

SouthState Corp sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 500 shares — an estimated $10.5K sold.

SouthState Corp first reported a position in IDYA in Q2 2025 and held it in 1 quarter. The position peaked at $10.5K in Q2 2025. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

SouthState Corp reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
SouthState Corp sold 500 IDEAYA Biosciences shares in Q3 2025, an estimated $10.5K.
SouthState Corp first reported a position in IDEAYA Biosciences in Q2 2025 and held it in 1 quarter.
SouthState Corp's IDEAYA Biosciences position peaked at $10.5K in Q2 2025.
224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on SouthState Corp's 13F filing for Q3 2025, filed 5 Nov 2025.